Temporary exacerbation of pre-existing psoriasis and eczema in the context of COVID-19 messenger RNA booster vaccination: A case report and review of the literature

JAAD Int. 2022 Mar:6:94-96. doi: 10.1016/j.jdin.2021.11.004. Epub 2021 Dec 18.
No abstract available

Keywords: COVID-19; FDA, Food and Drug Administration; booster; drugs; eczema; immunosuppression; psoriasis; rashes; vaccination.

Publication types

  • Editorial